Oncolytics Biotech (ONCY) Completes Enrollment in REOLYSIN w/ Aclitaxel and Carboplatin Phase III
Go back to Oncolytics Biotech (ONCY) Completes Enrollment in REOLYSIN w/ Aclitaxel and Carboplatin Phase III| Oncolytics Biotech, Inc. (NASDAQ: ONCY) | Delayed: 0.83 -0.01 (1.19%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.84 | 52 Week High | $1.37 | |||
| Open | $0.84 | 52 Week Low | $0.24 | |||
| Day High | $0.86 | P/E | N/A | |||
| Day Low | $0.83 | EPS | $0.00 | |||
| Volume | 608,425 | |||||
